Shijiazhuang Yiling Pharmaceutical Co., Ltd. (SHE:002603)
China · Delayed Price · Currency is CNY 17.11
+0.22 (1.30%)
Aug 11, 2026, 1:05 PM CST
SHE:002603 Revenue
Shijiazhuang Yiling Pharmaceutical had revenue of 2.44B CNY in the quarter ending March 31, 2026, with 3.46% growth. This brings the company's revenue in the last twelve months to 7.91B, up 24.64% year-over-year. In the year 2025, Shijiazhuang Yiling Pharmaceutical had annual revenue of 7.83B with 20.24% growth.
Revenue (ttm)
7.91B
Revenue Growth
+24.64%
P/S Ratio
3.57
Revenue / Employee
697.55K
Employees
11,343
Market Cap
28.22B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 7.83B | 1.32B | 20.24% |
| Dec 31, 2024 | 6.51B | -3.81B | -36.88% |
| Dec 31, 2023 | 10.32B | -2.21B | -17.67% |
| Jan 1, 2023 | 12.53B | 2.42B | 23.88% |
| Jan 1, 2022 | 10.12B | 1.33B | 15.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 1, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
Revenue RankingsShijiazhuang Yiling Pharmaceutical News
- 3 months ago - Shijiazhuang Yiling Pharmaceutical Annual report: Q4 2025 - Filings
- 3 months ago - Shijiazhuang Yiling Pharmaceutical Quarterly report: Q1 2026 - Filings
- 10 months ago - Shijiazhuang Yiling Pharmaceutical Quarterly report: Q3 2025 - Filings
- 1 year ago - Shijiazhuang Yiling Pharmaceutical Quarterly report: Q2 2025 - Filings